OCUGEN, INC. Total Assets
OCUGEN, INC. (OCGN) had Total Assets of $124.21 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $124.21M.
- 2026-03-31: Assets $56.91M.
- 2025-12-31: Assets $43.52M.
- 2025-09-30: Assets $57.60M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $124.21M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $56.91M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $43.52M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $57.60M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $53.59M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $64.46M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $82.44M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $61.94M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $40.54M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $51.79M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $64.55M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $74.69M 10-K · filed 2024-04-16 | |
| 2023-06-30 | $88.98M 10-K · filed 2024-04-16 | |
| 2023-03-31 | $96.30M 10-K · filed 2024-04-16 | |
| 2022-12-31 | $108.63M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $116.24M 10-K · filed 2024-04-16 | |
| 2022-06-30 | $130.09M 10-K · filed 2024-04-16 | |
| 2022-03-31 | $141.73M 10-K · filed 2024-04-16 | |
| 2021-12-31 | $105.76M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $116.31M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $124.25M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $53.85M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $27.38M 10-K · filed 2022-02-28 | $27.38M 10-K · filed 2021-03-19 |
| 2020-09-30 | $20.54M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $23.76M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $12.31M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $16.81M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $23.62M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $4.12M 8-K/A · filed 2019-10-07 | $3.20M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $14.84M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.45M 10-K · filed 2020-03-27 | $17.43M 10-K · filed 2019-03-22 |
| 2018-09-30 | $10.88M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $15.15M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $21.32M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $11.04M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $15.83M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $22.13M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $28.31M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $36.08M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $42.80M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $21.28M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $28.52M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $36.79M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $45.30M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $53.24M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $61.58M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $65.50M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |